| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.081 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |